Introduction: Cardiac arrhythmias usually occur in the presence of abnormal substrate that is responsible for creating and disturbed conduction of impulses. Ischemic heart disease is the primary cause of the development of ventricular fibrillation, and also the other, as hypertrophic and dilated cardiomyopathy make up the most of the cases. In a post-mortem series of victims of cardiac arrest, structural abnormalities were absent in 5-8 % and they have been, for many years, called idiopathic ventricular fibrillation (IVF). Now, with the help of molecular biologists, substrate IVF is practically defined. In less than a decade, the essential facts suggest that genetically determined abnormalities in the proteins that control the electrical activity can cause cardiac arrest in a structurally intact heart. Finally, at least nine genes are associated with inherited arrhythmogenic diseases and the number of genes is expected to be even higher. The advances in molecular biology reveal the causes of sudden cardiac death (SCD) in patients with morphologically normal myocardium. The term channelopathies is introduced for the diseases such as long QT syndrome, Brugada syndrome, etc.
